January, 2023: Charité 3R call „human 3D models for replacement or reduction”
An autologous model of the adaptive immune response in human lung organoids: Targeting infection with influenza-specific T-cells
firmennest17
February, 2022: Research article: Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients
Peter, L., Wendering, D. J., Schlickeiser, S., Hoffmann, H., Noster, R., Wagner, D. L., Zarrinrad, G., Münch, S., Picht, S., Schulenberg, S., Moradian, H., Mashreghi, M. F., Klein, O., Gossen,…